Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
